292 related articles for article (PubMed ID: 25669984)
21. MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.
De Mattos-Arruda L; Bottai G; Nuciforo PG; Di Tommaso L; Giovannetti E; Peg V; Losurdo A; Pérez-Garcia J; Masci G; Corsi F; Cortés J; Seoane J; Calin GA; Santarpia L
Oncotarget; 2015 Nov; 6(35):37269-80. PubMed ID: 26452030
[TBL] [Abstract][Full Text] [Related]
22. Notch-1 contributes to epidermal growth factor receptor tyrosine kinase inhibitor acquired resistance in non-small cell lung cancer in vitro and in vivo.
Xie M; He CS; Wei SH; Zhang L
Eur J Cancer; 2013 Nov; 49(16):3559-72. PubMed ID: 23916913
[TBL] [Abstract][Full Text] [Related]
23. Dual PI3K/mTOR inhibitor BEZ235 exerts extensive antitumor activity in HER2-positive gastric cancer.
Zhu Y; Tian T; Zou J; Wang Q; Li Z; Li Y; Liu X; Dong B; Li N; Gao J; Shen L
BMC Cancer; 2015 Nov; 15():894. PubMed ID: 26560145
[TBL] [Abstract][Full Text] [Related]
24. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade.
Ma J; Meng Y; Kwiatkowski DJ; Chen X; Peng H; Sun Q; Zha X; Wang F; Wang Y; Jing Y; Zhang S; Chen R; Wang L; Wu E; Cai G; Malinowska-Kolodziej I; Liao Q; Liu Y; Zhao Y; Sun Q; Xu K; Dai J; Han J; Wu L; Zhao RC; Shen H; Zhang H
J Clin Invest; 2010 Jan; 120(1):103-14. PubMed ID: 20038814
[TBL] [Abstract][Full Text] [Related]
25. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1.
Lu J; Ye X; Fan F; Xia L; Bhattacharya R; Bellister S; Tozzi F; Sceusi E; Zhou Y; Tachibana I; Maru DM; Hawke DH; Rak J; Mani SA; Zweidler-McKay P; Ellis LM
Cancer Cell; 2013 Feb; 23(2):171-85. PubMed ID: 23375636
[TBL] [Abstract][Full Text] [Related]
26. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer.
Kim HP; Han SW; Song SH; Jeong EG; Lee MY; Hwang D; Im SA; Bang YJ; Kim TY
Oncogene; 2014 Jun; 33(25):3334-41. PubMed ID: 23873022
[TBL] [Abstract][Full Text] [Related]
27. Endothelial Jagged1 promotes solid tumor growth through both pro-angiogenic and angiocrine functions.
Pedrosa AR; Trindade A; Carvalho C; Graça J; Carvalho S; Peleteiro MC; Adams RH; Duarte A
Oncotarget; 2015 Sep; 6(27):24404-23. PubMed ID: 26213336
[TBL] [Abstract][Full Text] [Related]
28. Twist1 induces endothelial differentiation of tumour cells through the Jagged1-KLF4 axis.
Chen HF; Huang CH; Liu CJ; Hung JJ; Hsu CC; Teng SC; Wu KJ
Nat Commun; 2014 Aug; 5():4697. PubMed ID: 25146389
[TBL] [Abstract][Full Text] [Related]
29. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged-1 signaling and paracrine mechanisms: clues for cardiac regeneration.
Sassoli C; Pini A; Mazzanti B; Quercioli F; Nistri S; Saccardi R; Zecchi-Orlandini S; Bani D; Formigli L
J Mol Cell Cardiol; 2011 Sep; 51(3):399-408. PubMed ID: 21712044
[TBL] [Abstract][Full Text] [Related]
31. Jagged-1 is required for the expansion of CD4+ CD25+ FoxP3+ regulatory T cells and tolerogenic dendritic cells by murine mesenchymal stromal cells.
Cahill EF; Tobin LM; Carty F; Mahon BP; English K
Stem Cell Res Ther; 2015 Mar; 6(1):19. PubMed ID: 25890330
[TBL] [Abstract][Full Text] [Related]
32. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.
Osipo C; Patel P; Rizzo P; Clementz AG; Hao L; Golde TE; Miele L
Oncogene; 2008 Aug; 27(37):5019-32. PubMed ID: 18469855
[TBL] [Abstract][Full Text] [Related]
33. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
[TBL] [Abstract][Full Text] [Related]
34. TNF-α-inducing protein of Helicobacter pylori induces epithelial-mesenchymal transition (EMT) in gastric cancer cells through activation of IL-6/STAT3 signaling pathway.
Chen G; Tang N; Wang C; Xiao L; Yu M; Zhao L; Cai H; Han L; Xie C; Zhang Y
Biochem Biophys Res Commun; 2017 Mar; 484(2):311-317. PubMed ID: 28130110
[TBL] [Abstract][Full Text] [Related]
35. Jagged-1 signaling suppresses the IL-6 and TGF-β treatment-induced Th17 cell differentiation via the reduction of RORγt/IL-17A/IL-17F/IL-23a/IL-12rb1.
Wang Y; Xing F; Ye S; Xiao J; Di J; Zeng S; Liu J
Sci Rep; 2015 Feb; 5():8234. PubMed ID: 25648768
[TBL] [Abstract][Full Text] [Related]
36. Combating acquired resistance to trastuzumab by an anti-ErbB2 fully human antibody.
Wang C; Wang L; Yu X; Zhang Y; Meng Y; Wang H; Yang Y; Gao J; Wei H; Zhao J; Lu C; Chen H; Sun Y; Li B
Oncotarget; 2017 Jun; 8(26):42742-42751. PubMed ID: 28514745
[TBL] [Abstract][Full Text] [Related]
37. Cellular analysis of growth suppression induced by the Notch ligands, Delta-1 and Jagged-1 in two myeloid leukemia cell lines.
Murata-Ohsawa M; Tohda S; Nara N
Int J Mol Med; 2004 Aug; 14(2):223-6. PubMed ID: 15254769
[TBL] [Abstract][Full Text] [Related]
38. A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway.
Liu J; Pan C; Guo L; Wu M; Guo J; Peng S; Wu Q; Zuo Q
J Hematol Oncol; 2016 Aug; 9(1):76. PubMed ID: 27581375
[TBL] [Abstract][Full Text] [Related]
39. Inorganic kernel - Supported asymmetric hybrid vesicles for targeting delivery of STAT3-decoy oligonucleotides to overcome anti-HER2 therapeutic resistance of BT474R.
Shi K; Fang Y; Gao S; Yang D; Bi H; Xue J; Lu A; Li Y; Ke L; Lin X; Jin X; Li M
J Control Release; 2018 Jun; 279():53-68. PubMed ID: 29655990
[TBL] [Abstract][Full Text] [Related]
40. Development of trastuzumab-resistant human gastric carcinoma cell lines and mechanisms of drug resistance.
Zuo Q; Liu J; Zhang J; Wu M; Guo L; Liao W
Sci Rep; 2015 Jun; 5():11634. PubMed ID: 26108989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
